BioNTech SE SEC filings BNTX

BioNTech SE has 589 filings in SEC EDGAR's recent list, going back to Jun 19, 2019. Its latest annual report, Form 20-F, was filed on Mar 10, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on December 31.

BioNTech SE SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Nov 3, 2026 Sep 30, 2026
6-K Current report (foreign issuer) Nov 3, 2026 Nov 3, 2026
6-K Current report (foreign issuer) Oct 26, 2026 Oct 26, 2026
6-K Current report (foreign issuer) Oct 26, 2026 Oct 26, 2026
6-K Current report (foreign issuer) Oct 22, 2026 Oct 22, 2026
6-K Current report (foreign issuer) Oct 19, 2026 Oct 19, 2026
6-K Current report (foreign issuer) Oct 13, 2026 Oct 13, 2026
4 Insider transaction Oct 9, 2026 Oct 8, 2026
4 Insider transaction Oct 7, 2026 Oct 7, 2026
4 Insider transaction Oct 6, 2026 Oct 5, 2026
4 Insider transaction Oct 2, 2026 Oct 1, 2026
4 Insider transaction Sep 30, 2026 Sep 29, 2026
4 Insider transaction Sep 28, 2026 Sep 25, 2026
4 Insider transaction Sep 24, 2026 Sep 23, 2026
4 Insider transaction Sep 22, 2026 Sep 21, 2026
4 Insider transaction Sep 18, 2026 Sep 17, 2026
6-K Current report (foreign issuer) Sep 18, 2026 Sep 18, 2026
4 Insider transaction Sep 16, 2026 Sep 15, 2026
4 Insider transaction Sep 14, 2026 Sep 11, 2026
6-K Current report (foreign issuer) Sep 14, 2026 Sep 14, 2026
4 Insider transaction Sep 11, 2026 Sep 10, 2026
4 Insider transaction Sep 9, 2026 Sep 8, 2026
4 Insider transaction Sep 8, 2026 Sep 3, 2026
144 Notice of proposed sale Sep 3, 2026 —
6-K Current report (foreign issuer) Aug 28, 2026 Aug 28, 2026
6-K Current report (foreign issuer) Aug 27, 2026 Aug 27, 2026
6-K Current report (foreign issuer) Aug 20, 2026 Aug 20, 2026
6-K Current report (foreign issuer) Aug 4, 2026 Jun 30, 2026
6-K Current report (foreign issuer) Aug 4, 2026 Aug 4, 2026
6-K Current report (foreign issuer) Aug 3, 2026 Aug 3, 2026
20-F/A Amended annual report (foreign issuer) Jul 30, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Jul 29, 2026 Jul 29, 2026
3 Initial insider ownership Jun 26, 2026 Jun 26, 2026
3 Initial insider ownership Jun 26, 2026 Jun 26, 2026
6-K Current report (foreign issuer) Jun 8, 2026 Jun 8, 2026
6-K Current report (foreign issuer) Jun 1, 2026 Jun 1, 2026
6-K Current report (foreign issuer) May 22, 2026 May 22, 2026
6-K Current report (foreign issuer) May 15, 2026 May 15, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2026 —
4 Insider transaction May 13, 2026 May 12, 2026
4 Insider transaction May 13, 2026 May 12, 2026
4 Insider transaction May 13, 2026 May 12, 2026
4 Insider transaction May 13, 2026 May 12, 2026
4 Insider transaction May 13, 2026 May 12, 2026
144 Notice of proposed sale May 12, 2026 —
6-K Current report (foreign issuer) May 7, 2026 May 7, 2026
6-K Current report (foreign issuer) May 5, 2026 Mar 31, 2026
6-K Current report (foreign issuer) May 5, 2026 May 5, 2026
4 Insider transaction Apr 23, 2026 Apr 22, 2026
3/A Form 3/a Apr 13, 2026 Mar 18, 2026
6-K Current report (foreign issuer) Apr 13, 2026 Apr 13, 2026
6-K Current report (foreign issuer) Apr 2, 2026 Apr 2, 2026
20-F/A Amended annual report (foreign issuer) Apr 1, 2026 Dec 31, 2025
3 Initial insider ownership Mar 25, 2026 Mar 18, 2026
3 Initial insider ownership Mar 25, 2026 Mar 18, 2026
3 Initial insider ownership Mar 25, 2026 Mar 18, 2026
3 Initial insider ownership Mar 25, 2026 Mar 18, 2026
3 Initial insider ownership Mar 25, 2026 Mar 18, 2026
3 Initial insider ownership Mar 25, 2026 Mar 18, 2026
3 Initial insider ownership Mar 25, 2026 Mar 18, 2026
6-K Current report (foreign issuer) Mar 24, 2026 Mar 24, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
144 Notice of proposed sale Mar 11, 2026 —
20-F Annual report (foreign issuer) Mar 10, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Mar 10, 2026 Mar 10, 2026
6-K Current report (foreign issuer) Mar 10, 2026 Mar 10, 2026
144 Notice of proposed sale Feb 12, 2026 —
6-K Current report (foreign issuer) Jan 28, 2026 Jan 28, 2026
6-K Current report (foreign issuer) Jan 14, 2026 Jan 13, 2026
6-K Current report (foreign issuer) Jan 12, 2026 Jan 12, 2026
6-K Current report (foreign issuer) Jan 6, 2026 Jan 6, 2026
SC TO-T/A Filing Dec 18, 2025 —
6-K Current report (foreign issuer) Dec 18, 2025 Dec 18, 2025
6-K Current report (foreign issuer) Dec 9, 2025 Dec 9, 2025
6-K Current report (foreign issuer) Dec 8, 2025 Dec 6, 2025
SC TO-T/A Filing Dec 3, 2025 —
425 Filing Dec 3, 2025 —
6-K Current report (foreign issuer) Dec 3, 2025 Dec 3, 2025
144 Notice of proposed sale Nov 28, 2025 —
SC TO-T/A Filing Nov 26, 2025 —
425 Filing Nov 26, 2025 —
6-K Current report (foreign issuer) Nov 26, 2025 Nov 26, 2025
424B3 Prospectus Nov 14, 2025 —
144 Notice of proposed sale Nov 13, 2025 —
425 Filing Nov 12, 2025 —
425 Filing Nov 12, 2025 —
6-K Current report (foreign issuer) Nov 12, 2025 Nov 12, 2025
144 Notice of proposed sale Nov 5, 2025 —
6-K Current report (foreign issuer) Nov 3, 2025 Sep 30, 2025
6-K Current report (foreign issuer) Nov 3, 2025 Nov 3, 2025
SC TO-T/A Filing Oct 22, 2025 —
425 Filing Oct 22, 2025 —
425 Filing Oct 22, 2025 —
6-K Current report (foreign issuer) Oct 22, 2025 Oct 22, 2025
SC TO-T Filing Oct 21, 2025 —
F-4/A Filing Oct 21, 2025 —
425 Filing Oct 20, 2025 —
425 Filing Oct 20, 2025 —
6-K Current report (foreign issuer) Oct 1, 2025 Oct 1, 2025
6-K Current report (foreign issuer) Sep 8, 2025 Sep 8, 2025
CORRESP Letter to the SEC Sep 8, 2025 —
F-4/A Filing Sep 8, 2025 —
6-K Current report (foreign issuer) Sep 8, 2025 Sep 8, 2025
144 Notice of proposed sale Sep 5, 2025 —
6-K Current report (foreign issuer) Sep 5, 2025 Sep 5, 2025
6-K Current report (foreign issuer) Aug 27, 2025 Aug 27, 2025
144 Notice of proposed sale Aug 15, 2025 —
144 Notice of proposed sale Aug 15, 2025 —
UPLOAD Letter from the SEC Aug 12, 2025 —
CORRESP Letter to the SEC Aug 11, 2025 —
F-4 Filing Aug 11, 2025 —
425 Filing Aug 11, 2025 —
6-K Current report (foreign issuer) Aug 11, 2025 Aug 11, 2025
425 Filing Aug 8, 2025 —
6-K Current report (foreign issuer) Aug 4, 2025 Jun 30, 2025
6-K Current report (foreign issuer) Aug 4, 2025 Aug 4, 2025
6-K Current report (foreign issuer) Jul 25, 2025 Jul 25, 2025
UPLOAD Letter from the SEC Jul 23, 2025 —
6-K Current report (foreign issuer) Jul 17, 2025 Jul 17, 2025
DRSLTR Filing Jun 30, 2025 —
DRS Filing Jun 30, 2025 —
6-K Current report (foreign issuer) Jun 17, 2025 Jun 17, 2025
425 Filing Jun 17, 2025 —
6-K Current report (foreign issuer) Jun 17, 2025 Jun 17, 2025
425 Filing Jun 12, 2025 —
425 Filing Jun 12, 2025 —
425 Filing Jun 12, 2025 —
425 Filing Jun 12, 2025 —
425 Filing Jun 12, 2025 —
6-K Current report (foreign issuer) Jun 12, 2025 Jun 12, 2025
144/A Filing Jun 4, 2025 —
144 Notice of proposed sale Jun 4, 2025 —
144 Notice of proposed sale Jun 2, 2025 —
6-K Current report (foreign issuer) Jun 2, 2025 Jun 2, 2025
144 Notice of proposed sale May 28, 2025 —
6-K Current report (foreign issuer) May 27, 2025 May 27, 2025
6-K Current report (foreign issuer) May 20, 2025 May 20, 2025
6-K Current report (foreign issuer) May 16, 2025 May 16, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 13, 2025 —
144 Notice of proposed sale May 7, 2025 —
6-K Current report (foreign issuer) May 5, 2025 May 5, 2025
6-K Current report (foreign issuer) May 5, 2025 May 5, 2025
6-K Current report (foreign issuer) May 5, 2025 May 5, 2025
6-K Current report (foreign issuer) Apr 24, 2025 Apr 24, 2025
6-K Current report (foreign issuer) Apr 4, 2025 Apr 4, 2025
6-K Current report (foreign issuer) Apr 2, 2025 Apr 2, 2025
20-F Annual report (foreign issuer) Mar 10, 2025 Dec 31, 2024
6-K Current report (foreign issuer) Mar 10, 2025 Mar 10, 2025
6-K Current report (foreign issuer) Mar 4, 2025 Mar 4, 2025
144 Notice of proposed sale Feb 27, 2025 —
144 Notice of proposed sale Feb 20, 2025 —
144 Notice of proposed sale Feb 20, 2025 —
6-K Current report (foreign issuer) Feb 3, 2025 Feb 3, 2025
6-K Current report (foreign issuer) Jan 14, 2025 Jan 14, 2025
6-K Current report (foreign issuer) Dec 27, 2024 Dec 27, 2024
6-K Current report (foreign issuer) Dec 27, 2024 Dec 27, 2024
144 Notice of proposed sale Dec 13, 2024 —
6-K Current report (foreign issuer) Dec 13, 2024 Dec 13, 2024
144 Notice of proposed sale Dec 11, 2024 —
144 Notice of proposed sale Dec 9, 2024 —
144 Notice of proposed sale Dec 6, 2024 —
144 Notice of proposed sale Nov 27, 2024 —
144 Notice of proposed sale Nov 26, 2024 —
144 Notice of proposed sale Nov 25, 2024 —
144 Notice of proposed sale Nov 15, 2024 —
6-K Current report (foreign issuer) Nov 14, 2024 Nov 14, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 13, 2024 —
6-K Current report (foreign issuer) Nov 13, 2024 Nov 13, 2024
144 Notice of proposed sale Nov 12, 2024 —
6-K Current report (foreign issuer) Nov 4, 2024 Sep 30, 2024
6-K Current report (foreign issuer) Nov 4, 2024 Nov 4, 2024
6-K Current report (foreign issuer) Oct 18, 2024 Oct 18, 2024
144 Notice of proposed sale Oct 16, 2024 —
144 Notice of proposed sale Oct 15, 2024 —
144 Notice of proposed sale Oct 11, 2024 —
144 Notice of proposed sale Oct 10, 2024 —
144 Notice of proposed sale Oct 9, 2024 —
144 Notice of proposed sale Oct 8, 2024 —
144 Notice of proposed sale Oct 7, 2024 —
144 Notice of proposed sale Oct 4, 2024 —
144 Notice of proposed sale Oct 3, 2024 —
144 Notice of proposed sale Oct 2, 2024 —
144 Notice of proposed sale Oct 1, 2024 —
6-K Current report (foreign issuer) Oct 1, 2024 Oct 1, 2024
144 Notice of proposed sale Sep 30, 2024 —
144 Notice of proposed sale Sep 27, 2024 —
144 Notice of proposed sale Sep 25, 2024 —
6-K Current report (foreign issuer) Sep 20, 2024 Sep 20, 2024
144 Notice of proposed sale Sep 18, 2024 —
144 Notice of proposed sale Sep 17, 2024 —
144 Notice of proposed sale Sep 16, 2024 —
144 Notice of proposed sale Sep 16, 2024 —
144 Notice of proposed sale Sep 13, 2024 —
6-K Current report (foreign issuer) Sep 5, 2024 Sep 5, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
BNTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Germany
Headquarters
Mainz, Germany
SEC filer status
Large accelerated filer
SEC CIK
1776985

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.